Home

parità giardino mod federica mazzuca oncologia cattivo umore Elastico Può resistere

Curriculum Vitae Europass
Curriculum Vitae Europass

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Prof.ssa Federica Mazzuca: oncologa a Roma
Prof.ssa Federica Mazzuca: oncologa a Roma

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Prof.ssa Federica Mazzuca: oncologa a Roma
Prof.ssa Federica Mazzuca: oncologa a Roma

Codon-specific KRAS mutations predict survival benefit of  trifluridine/tipiracil in metastatic colorectal cancer | Nature Medicine
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer | Nature Medicine

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

tt- w\
tt- w\

Expert Meeting EXTRAppeal Sardara, 20 settembre ppt scaricare
Expert Meeting EXTRAppeal Sardara, 20 settembre ppt scaricare

Federica Mazzuca - Ricercatore Universitario - Dirigente Medico -  University of Rome "La Sapienza" | LinkedIn
Federica Mazzuca - Ricercatore Universitario - Dirigente Medico - University of Rome "La Sapienza" | LinkedIn

Oncologia Integrata | Sapienza Università di Roma
Oncologia Integrata | Sapienza Università di Roma

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Prof.ssa Federica Mazzuca: oncologa a Roma
Prof.ssa Federica Mazzuca: oncologa a Roma

Prof.ssa Federica Mazzuca: oncologa a Roma
Prof.ssa Federica Mazzuca: oncologa a Roma

X CONGRESSO INTERNAZIONALE ARTOI “Oncologia Integrata. Una Risorsa per la  Salute e la Cura personalizzata del paziente” – AMeC APS
X CONGRESSO INTERNAZIONALE ARTOI “Oncologia Integrata. Una Risorsa per la Salute e la Cura personalizzata del paziente” – AMeC APS

Master in Oncologia Integrata Roma
Master in Oncologia Integrata Roma

Focus in mmunoOncologia
Focus in mmunoOncologia

Master in Oncologia Integrata Roma
Master in Oncologia Integrata Roma

Cascinu Stefano Università Vita-Salute San Raffaele
Cascinu Stefano Università Vita-Salute San Raffaele

Prof.ssa Federica Mazzuca: oncologa a Roma
Prof.ssa Federica Mazzuca: oncologa a Roma

IEO Istituto Europeo di Oncologia | Facebook
IEO Istituto Europeo di Oncologia | Facebook

Premio Roma - Albo d'oro 2018
Premio Roma - Albo d'oro 2018

Terapie integrate e terapie convenzionali in oncologia
Terapie integrate e terapie convenzionali in oncologia

Review Article Bevacizumab as first line treatment in HER2-negative  advanced breast cancer: pros and cons
Review Article Bevacizumab as first line treatment in HER2-negative advanced breast cancer: pros and cons

Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza |  Department of Clinical and Molecular Medicine | Research profile
Federica MAZZUCA | Sapienza University of Rome, Rome | la sapienza | Department of Clinical and Molecular Medicine | Research profile

Federica Mazzuca, la ricercatrice in oncologia che ha vinto il premio Roma  - YouTube
Federica Mazzuca, la ricercatrice in oncologia che ha vinto il premio Roma - YouTube